BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27431754)

  • 1. De Novo CD5-Positive Diffuse Large B-Cell Lymphoma: Report of a Case Presenting With Cutaneous Involvement and Featuring Extensive Intravascular Dissemination on Postmortem Examination.
    Úbeda Romero A; Santonja C; Blanco García A; Requena L; Rodríguez Pinilla SM
    Int J Surg Pathol; 2016 Dec; 24(8):763-768. PubMed ID: 27431754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs.
    Ueno S; Yamaguchi M; Kimura M; Odagiri H; Shiraki K; Uemoto S; Nakamura N; Zhang W; Shiku H; Kobayashi T
    Int J Oncol; 2005 Nov; 27(5):1241-6. PubMed ID: 16211218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas.
    Kobayashi T; Yamaguchi M; Kim S; Morikawa J; Ogawa S; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W
    Cancer Res; 2003 Jan; 63(1):60-6. PubMed ID: 12517778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diffuse large B-cell lymphoma with intravascular involvement of neoplastic CD5-positive cells].
    Matsuoka N; Sano N; Murayama T; Ueda K; Hashimoto H; Inoki T; Hirokawa Y; Yamaguchi M; Katayama N
    Rinsho Ketsueki; 2013 Dec; 54(12):2199-202. PubMed ID: 24452153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo CD5-positive primary cardiac diffuse large B-cell lymphoma diagnosed by pleural fluid cytology.
    Cioc AM; Jessurun J; Vercellotti GM; Pambuccian SE
    Diagn Cytopathol; 2014 Mar; 42(3):259-67. PubMed ID: 23007953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
    Yamaguchi M; Nakamura N; Suzuki R; Kagami Y; Okamoto M; Ichinohasama R; Yoshino T; Suzumiya J; Murase T; Miura I; Ohshima K; Nishikori M; Tamaru J; Taniwaki M; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
    Haematologica; 2008 Aug; 93(8):1195-202. PubMed ID: 18556402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: a case report with literature review.
    Zhang X; Sun M; Zhang L; Shao H
    Int J Clin Exp Pathol; 2013; 6(5):985-9. PubMed ID: 23638236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma.
    Suzuki Y; Sakakibara A; Shimada K; Shimada S; Ishikawa E; Nakamura S; Kato S; Takahara T; Asano N; Satou A; Kohno K
    Pathol Int; 2019 Jan; 69(1):13-20. PubMed ID: 30601579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo CD5+ Primary Gastrointestinal Diffuse Large B-Cell Lymphoma: Challenges With Treatment and Clinical Course.
    Ramachandran P; Sahni S; Wang JC
    J Investig Med High Impact Case Rep; 2019; 7():2324709619893546. PubMed ID: 31814435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases.
    Khalidi HS; Brynes RK; Browne P; Koo CH; Battifora H; Medeiros LJ
    Mod Pathol; 1998 Oct; 11(10):983-8. PubMed ID: 9796727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 10 patients with de novo CD5 positive diffuse large B cell lymphoma].
    Zhang Q; Zhang HY; Zhong FL; Zhang WL; Xu L; Feng J; Meng QX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):399-402. PubMed ID: 23628041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival.
    Yoshioka T; Miura I; Kume M; Takahashi N; Okamoto M; Ichinohasama R; Yoshino T; Yamaguchi M; Hirokawa M; Sawada K; Nakamura S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):149-57. PubMed ID: 15543600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [De novo CD5-positive diffuse large B-cell lymphoma with leukemic dissemination diagnosed by immunohistochemical examinations of bone marrow clot sections].
    Yoshida K; Kayano H; Akiba M; Kishimoto K; Takahashi N; Sugahara Y; Kawai N; Matsuda A; Hirashima K; Suzuki T; Bessho M
    Rinsho Ketsueki; 2002 Oct; 43(10):943-8. PubMed ID: 12462031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in CD5-positive Diffuse Large B Cell Lymphoma: A Morphometric Analysis.
    Woźnialis N; Gierej B; Popławska L; Ziarkiewicz M; Wolińska E; Kulczycka E; Ziarkiewicz-Wróblewska B
    Adv Clin Exp Med; 2016; 25(6):1149-1155. PubMed ID: 28028967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of
    Singh D; Kapuria D; Nanua S; Gaur R
    Case Rep Hematol; 2016; 2016():6239416. PubMed ID: 27777803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Secondary to Chronic Lymphedema.
    Sun L; Sun Y; Xin W; He J; Hu Y; Zhang H; Yu J; Zhang JA
    Am J Dermatopathol; 2022 Mar; 44(3):179-182. PubMed ID: 35171885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma.
    Hyo R; Tomita N; Takeuchi K; Aoshima T; Fujita A; Kuwabara H; Hashimoto C; Takemura S; Taguchi J; Sakai R; Fujita H; Fujisawa S; Ogawa K; Motomura S; Suzuki R; Ishigatsubo Y
    Hematol Oncol; 2010 Mar; 28(1):27-32. PubMed ID: 19358143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean.
    Kong SY; Cho EH; Woo HY; Park Q; Ko YH; Kim SH
    J Korean Med Sci; 2004 Dec; 19(6):815-9. PubMed ID: 15608391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.